Symbol Lookup
THORATEC Add to My Watchlist (NSDQ: THOR) 

     Thoratec Corp 29.79 +0.06 (+0.20%) 907,420
Screen News & Media for THOR
Tuesday, November 24, 2009
01:00 PM Thoratec Presentation at Piper Jaffray Conference to be Webcast PR Newswire
Monday, November 23, 2009
02:57 PM HeartWare files for destination therapy IDE MassDevice - Medical...
12:00 AM Most Recent Ebitda data for Thoratec now available StockTrendNews.com t...
12:00 AM Most Recent Ebitda data for Thoratec now available StockTrendNews.com e...
Thursday, November 19, 2009
10:55 AM Lazard Capital's Biotech/Pharmaceuticals research team hosts a conference call theflyonthewall.com
12:00 AM OPS Ranking released by StockDiagnostics on Thoratec StockTrendNews.com o...
12:00 AM Thoratec's Cash Flow now available from CFFO_NEWS StockTrendNews.com c...
12:00 AM Free-Cash-News now has most Recent Free Cash Flow Data available for Thoratec StockTrendNews.com f...
12:00 AM Thoratec's Annualized Revenue Data Now Available From T12-NEWS StockTrendNews.com s...
12:00 AM OPS Ranking released by StockDiagnostics on Thoratec StockTrendNews.com t...
Wednesday, November 18, 2009
09:56 AM Auriga Reiterates a 'Buy' Rating on Thoratec Corp. (THOR); Strong Pivotal Data Should Lead to DT Approval StreetInsider
08:48 AM Thoratec HeartMate II should have strong launch in near future, says Wedbush theflyonthewall.com
07:04 AM Thoratec data should lead to accelerating adoption, says Leerink theflyonthewall.com
Tuesday, November 17, 2009
02:39 PM Thoratec (THOR) Is One of Today's Top Gainers On Heart Pump Study Results MarketIntelligenceCe...
01:47 PM Thoratec Lab (THOR) volatility decreases as shares rally 10% on positive trial data StreetInsider
01:32 PM JP Morgan's Healthcare Equipment Analyst hosts a conference call theflyonthewall.com
12:44 PM Markets Flat Over Disappointing Earnings MarketMinute.com Mar...
08:36 AM Thoratec announces trial data for HeartMate II over HeartMate XVE theflyonthewall.com
08:31 AM Thoratec (THOR) Releases Data for HeartMate II Pivotal Trial StreetInsider
08:00 AM Destination Therapy Trial Data Demonstrate Superiority for HeartMate II(R) Over HeartMate(R) XVE PR Newswire
   
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Stock News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs
E-mail Article to a Friend